# Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ai-25-013-limited-competition-national-biocontainment-laboratories/  
Official notice: https://www.grants.gov/search-results-detail/358892

> National Institutes of Health offered grants to colleges and universities. Applications closed on November 7, 2025.

| Field | Value |
|---|---|
| Opportunity number | RFA-AI-25-013 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | November 7, 2025 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.855 |

## Who can apply

- Public and State controlled institutions of higher education
- Private institutions of higher education

Other Eligible Applicants include the following: Eligible Organizations: The University of Texas Medical Branch at Galveston, TX and Boston University, Boston, MA Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

## What the grant funds

The goal of this notice of funding opportunity (NOFO) is to continue to provide operations support to the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs serve as a national resource for efforts in conducting pre-clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAIDs biodefense and emerging infectious diseases research efforts. Additionally, in times of a national biodefense or emerging infectious disease (EID) emergency, the NBLs may be expected to rapidly realign their activities to assist response efforts within the US under the direction of NIAID.

## Questions people ask

### Is RFA-AI-25-013 still open?

No. It closed on November 7, 2025.

### Who can apply for Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)?

National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)?

Closed November 7, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-AI-25-013?

NIH RePORTER lists 2 projects funded under RFA-AI-25-013 in fiscal 2026, at 2 institutions. The most were at Boston University Medical Campus, University of Texas Med BR Galveston.

### Who has won Allergy and Infectious Diseases Research grants before?

The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.